As the most important anti-tumor effector cells, activated CD8+ T cells eliminate tumor cells through recognition by their expressed T cell receptors of tumor-associated antigens on major histocompatibility complex I (MHC I) (Gajewski et al., 2013). Here, CD8A is linked to neoplasm.